UCB, INC.

Lobbying for UCB, INC.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Expenses

$340,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

California

Official filing document

Government bodies contacted 4

HOUSE OF REPRESENTATIVES
Intl Trade Administration (ITA)
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 4993
Joe Fiandra Access to Home Infusion Act of 2025

Lobbying activity 2

Pharmacy

HR 4993 - Joe Fiandra Access to Home Infusion Act

Trade (domestic/foreign)

Sec. 232 Pharmaceutical Tariffs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.